Patent 8582789

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (2)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

Current assignee: IngenioSpec LLC

1 settled1 discretionary denial
Discretionary Denial
Filed
Nov 21, 2025
Last modified
May 20, 2026
Petitioner
Apple Inc.
Inventor
Kwok Wai Cheung et al
Terminated-Settled
Filed
Sep 19, 2025
Last modified
Nov 18, 2025
Petitioner
Bose Corporation
Inventor
Kwok Wai Cheung et al

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

Two AIA trial proceedings have been filed against US Patent 8,582,789. One IPR (IPR2025-01547) was terminated due to settlement, and another (IPR2026-00144) was denied institution on discretionary grounds. This indicates that no claims of US8582789 have been invalidated at the PTAB, presenting a hardened defensive posture for the patent owner, as the patent has survived attempts to challenge its claims via IPR.

IPR2026-00144 — [Apple Inc.](/litigations/by-plaintiff/Apple%20Inc.) v. Ingeniospec LLC

  • Type: Inter Partes Review
  • Filed: 2025-11-21
  • Status: Discretionary Denial — The PTAB declined to institute the IPR, not necessarily on the merits of the obviousness/anticipation challenge, but based on procedural or policy considerations.
  • Judge panel: Information regarding the specific judge panel for this discretionary denial is not immediately available from public summaries without accessing the full PTAB order.
  • Petition grounds: Details of the specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for IPR2026-00144 are not readily available in public summaries for discretionary denials.
  • Institution decision: Denied (date not specified in provided information, but the last modified date is 2026-05-20, indicating a recent decision). The denial was discretionary, suggesting factors beyond the merits of patentability may have influenced the decision (e.g., related district court litigation, as suggested by "PTAB case IPR2026-00144 filed (Not Instituted - Procedural)" on Google Patents).
  • Final Written Decision: Not issued, as institution was denied.
  • Settlement / termination: Not applicable.
  • Appeal: Not applicable, as institution was denied.
  • Defensive value: This proceeding indicates that Apple Inc.'s challenge to the patent did not proceed to trial. While the claims were not upheld on the merits, the denial of institution means the claims remain untouched by this specific IPR. For a potential defendant, this signals that previous challenges have faced procedural hurdles at the institution stage.

IPR2025-01547 — Bose Corporation v. Ingeniospec LLC

  • Type: Inter Partes Review
  • Filed: 2025-09-19
  • Status: Terminated-Settled — The parties involved reached a settlement agreement, leading to the termination of the IPR proceeding.
  • Judge panel: Information regarding the specific judge panel for this settled IPR is not immediately available from public summaries without accessing the full PTAB order.
  • Petition grounds: Details of the specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) for IPR2025-01547 are not readily available in public summaries for settled cases.
  • Institution decision: The outcome of the institution decision (instituted/denied/partially instituted) for IPR2025-01547 before its termination due to settlement is not explicitly stated in the provided information.
  • Final Written Decision: Not issued, as the proceeding was terminated due to settlement.
  • Settlement / termination: The proceeding was terminated due to settlement, with a last modified date of 2025-11-18. The specific terms of the settlement are confidential.
  • Appeal: Not applicable, as the proceeding was terminated due to settlement.
  • Defensive value: This settlement indicates that Bose Corporation and the patent owner resolved their dispute, likely with an agreement that prevented a final PTAB decision on the merits. For a defendant facing assertion of this patent, it means that the challenged claims have not been invalidated by this IPR. However, it doesn't confirm their patentability or non-patentability, as the merits were not fully adjudicated. The confidential nature of the settlement means the terms are unknown.

Strategic summary

Currently, no claims of US Patent 8,582,789 have been canceled through AIA trial proceedings. IPR2025-01547, filed by Bose Corporation, was terminated due to a settlement, meaning the claims challenged in that petition were not adjudicated to a Final Written Decision. IPR2026-00144, filed by Apple Inc., was met with a discretionary denial of institution, implying the PTAB chose not to proceed with a full review, likely on procedural grounds rather than a full assessment of the prior art. Therefore, all claims of US8582789 remain untested by a Final Written Decision at the PTAB.

The estoppel landscape is relatively clear given the outcomes. For IPR2026-00144, since institution was denied, the petitioner (Apple Inc.) and its privies would generally not be estopped under 35 U.S.C. § 315(e)(2) from raising the same grounds or any grounds that could have been reasonably raised in future proceedings, as a trial was never instituted. For IPR2025-01547, because it was terminated by settlement, the estoppel effects depend heavily on the terms of the confidential settlement agreement. Absent specific details, it is difficult to definitively state which prior-art grounds are still available to the petitioner (Bose Corporation) or its privies. However, for other potential defendants not in privy with Bose, the prior art grounds remain available for challenge.

The pattern of activity shows two significant tech companies, Bose and Apple, have engaged with this patent at the PTAB. Bose settled its challenge, and Apple's challenge was denied institution. This suggests the patent owner, Ingeniospec LLC, has successfully defended the patent against these initial IPR attempts without any claims being invalidated. The mention of "Unified Patents Litigation Data" and "Unified Patents PTAB Data" on Google Patents in relation to other litigation cases for this patent family suggests a defensive aggregator might be involved in monitoring or supporting challenges, but neither of the identified IPRs list Unified Patents as the petitioner.

Recommended next steps

Given that no claims of US8582789 have been invalidated by a Final Written Decision from the PTAB, a defendant facing assertion of this patent would need to conduct thorough due diligence on the specific grounds and prior art presented in IPR2025-01547 and IPR2026-00144.

  • For IPR2026-00144, the discretionary denial means the PTAB did not rule on the merits of patentability. It would be crucial to obtain the institution decision to understand the precise reasoning for the denial. If the denial was based on Fintiv factors (parallel district court litigation), an accused infringer might still consider an IPR if their litigation posture differs significantly from Apple's.
  • For IPR2025-01547, the settlement makes it difficult to ascertain the strength of Bose's challenge or the claims' vulnerability. A potential defendant should analyze the prior art Bose presented in its petition (if publicly accessible) to evaluate if similar grounds could be re-raised in a new IPR, assuming no privity with Bose and no other estoppel applies.

The current legal status of the patent is "Active, expires 2026-11-26". This means the patent has only a few months of life remaining. Any defensive strategy, including a new IPR, would need to consider this very limited remaining term, which significantly impacts the cost-benefit analysis of such a proceeding.

Generated 5/27/2026, 12:48:18 AM